CRNX - Crinetics Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CRNX is currently covered by 8 analysts with an average price target of $82.01. This is a potential upside of $39.16 (91.39%) from yesterday's end of day stock price of $42.85.

Crinetics Pharmaceuticals's activity chart (see below) currently has 108 price targets and 87 ratings on display. The stock rating distribution of CRNX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.8% with an average time for these price targets to be met of 438.17 days.

Highest price target for CRNX is $143, Lowest price target is $52, average price target is $86.25.

Most recent stock forecast was given by LELAND GERSHELL from OPPENHEIMER on 29-Sep-2025. First documented stock forecast 12-Aug-2018.

Currently out of the existing stock ratings of CRNX, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$87

$45.43 (109.29%)

$73

22 days ago
(29-Sep-2025)

5/8 (62.5%)

$45.35 (108.88%)

146

Buy

$88

$46.43 (111.69%)

$39

23 days ago
(28-Sep-2025)

2/3 (66.67%)

$44.49 (102.25%)

1326

Buy

$77

$35.43 (85.23%)

$70

23 days ago
(28-Sep-2025)

1/3 (33.33%)

$33.49 (76.97%)

113

Buy

$143

$101.43 (244.00%)

$86

26 days ago
(25-Sep-2025)

9/18 (50%)

$97.09 (211.48%)

394

Buy

$62

$20.43 (49.15%)

$62

26 days ago
(25-Sep-2025)

4/6 (66.67%)

$16.09 (35.05%)

223

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRNX (Crinetics Pharmaceuticals) average time for price targets to be met?

On average it took 438.17 days on average for the stock forecasts to be realized with a an average price target met ratio 56.8

Which analyst has the current highest performing score on CRNX (Crinetics Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on CRNX (Crinetics Pharmaceuticals)?

Charles Duncan has 14 price targets and 8 ratings on CRNX

Which analyst is the currently most bullish on CRNX (Crinetics Pharmaceuticals)?

Jonathan Wolleben with highest potential upside - $101.43

Which analyst is the currently most reserved on CRNX (Crinetics Pharmaceuticals)?

Tyler Van Buren with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?